| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women
|
Bots, Sophie H.
|
|
2019
|
|
3 |
p. 258-266
|
artikel
|
| 2 |
A Machine Without an Owner’s Manual ∗
|
Rogers, Joseph G.
|
|
2016
|
|
3 |
p. 218-219
2 p.
|
artikel
|
| 3 |
A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices
|
Boehmer, John P.
|
|
2017
|
|
3 |
p. 216-225
10 p.
|
artikel
|
| 4 |
Angiotensin Receptor Neprilysin Inhibition Across Ejection Fraction and Acuity Spectra in Heart Failure ∗
|
Myhre, Peder L.
|
|
|
|
3 |
p. 583-587
|
artikel
|
| 5 |
A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
|
Segar, Matthew W.
|
|
|
|
3 |
p. 508-520
|
artikel
|
| 6 |
Are Cardiac Myosin Inhibitors Useful in Patients With Hypertrophic Obstructive Cardiomyopathy and Comorbid Hypertension? ∗
|
Sikand, Nikhil
|
|
|
|
3 |
p. 580-582
|
artikel
|
| 7 |
A Simplified Echocardiographic Strategy for Heart Failure Diagnosis and Management Within an Integrated Noncommunicable Disease Clinic at District Hospital Level for Sub-Saharan Africa
|
Kwan, Gene F.
|
|
2013
|
|
3 |
p. 230-236
7 p.
|
artikel
|
| 8 |
Association of Cardiomyopathy With Adverse Cardiac Events in Pregnant Women at the Time of Delivery
|
Lima, Fabio V.
|
|
2015
|
|
3 |
p. 257-266
10 p.
|
artikel
|
| 9 |
Association of Cardiorespiratory Fitness With Left Ventricular Remodeling and Diastolic Function
|
Brinker, Stephanie K.
|
|
2014
|
|
3 |
p. 238-246
9 p.
|
artikel
|
| 10 |
Association of Social Isolation and Loneliness With Incident Heart Failure in a Population-Based Cohort Study
|
Liang, Yannis Yan
|
|
|
|
3 |
p. 334-344
|
artikel
|
| 11 |
Atrial Fibrillation and Sudden Cardiac Death
|
Piccini, Jonathan P.
|
|
2014
|
|
3 |
p. 228-229
2 p.
|
artikel
|
| 12 |
Atrial Fibrillation Impairs the Diagnostic Performance of Cardiac Natriuretic Peptides in Dyspneic Patients
|
Richards, Mark
|
|
2013
|
|
3 |
p. 192-199
8 p.
|
artikel
|
| 13 |
Augmentation of Left Ventricular Wall Thickness With Alginate Hydrogel Implants Improves Left Ventricular Function and Prevents Progressive Remodeling in Dogs With Chronic Heart Failure
|
Sabbah, Hani N.
|
|
2013
|
|
3 |
p. 252-258
7 p.
|
artikel
|
| 14 |
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction
|
Solomon, Scott D.
|
|
|
|
3 |
p. 184-197
|
artikel
|
| 15 |
Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes
|
Pandey, Ambarish
|
|
|
|
3 |
p. 215-223
|
artikel
|
| 16 |
Biomarkers of Myocardial Stress and Fibrosis as Predictors of Mode of Death in Patients With Chronic Heart Failure
|
Ahmad, Tariq
|
|
2014
|
|
3 |
p. 260-268
9 p.
|
artikel
|
| 17 |
Bounded Rationality and Clinical Guidance Documents for Heart Failure
|
Thomas, Boban
|
|
|
|
3 |
p. 213
|
artikel
|
| 18 |
Can Vaccinations Improve Heart Failure Outcomes?
|
Bhatt, Ankeet S.
|
|
2017
|
|
3 |
p. 194-203
10 p.
|
artikel
|
| 19 |
Cardiopulmonary Exercise Testing-Based Risk Stratification in the Modern Era of Advanced Heart Failure Management ∗
|
Lewis, Gregory D.
|
|
|
|
3 |
p. 237-240
|
artikel
|
| 20 |
Chronotropy
|
Brubaker, Peter H.
|
|
2013
|
|
3 |
p. 267-269
3 p.
|
artikel
|
| 21 |
Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
|
Khan, Muhammad Shahzeb
|
|
|
|
3 |
p. 198-210
|
artikel
|
| 22 |
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction
|
Cohen, Jordana B.
|
|
|
|
3 |
p. 172-184
|
artikel
|
| 23 |
Clinical Trial Outcomes
|
Martinez, Robin
|
|
2019
|
|
3 |
p. 272-273
|
artikel
|
| 24 |
Coenzyme Q10
|
Mortensen, Svend Aage
|
|
2015
|
|
3 |
p. 270-271
2 p.
|
artikel
|
| 25 |
Complications and Mortality Following CRT-D Versus ICD Implants in Older Medicare Beneficiaries With Heart Failure
|
Zeitler, Emily P.
|
|
|
|
3 |
p. 147-157
|
artikel
|
| 26 |
Concerning the Role of Gender Difference in Obesity Paradox in Patients With Heart Failure
|
Emami, Amir
|
|
2016
|
|
3 |
p. 235-236
2 p.
|
artikel
|
| 27 |
Considering Addition of Acetazolamide to Loop Diuretics as Treatment for Acute Heart Failure
|
Greene, Stephen J.
|
|
|
|
3 |
p. 365-367
|
artikel
|
| 28 |
Contemporary Profile of Acute Heart Failure in Southern Nigeria
|
Ogah, Okechukwu S.
|
|
2014
|
|
3 |
p. 250-259
10 p.
|
artikel
|
| 29 |
CPET for Long COVID-19
|
Naeije, Robert
|
|
|
|
3 |
p. 214-215
|
artikel
|
| 30 |
Death, Heart Failure, and HIV
|
Manmathan, Gavin
|
|
|
|
3 |
p. 248-249
|
artikel
|
| 31 |
Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure
|
Tan, Eugene S.J.
|
|
|
|
3 |
p. 461-474
|
artikel
|
| 32 |
Distinct Pathological Pathways in Patients With Heart Failure and Diabetes
|
Tromp, Jasper
|
|
|
|
3 |
p. 234-242
|
artikel
|
| 33 |
Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure
|
Cox, Zachary L.
|
|
|
|
3 |
p. 157-168
|
artikel
|
| 34 |
Donor Heart Recovery and Preservation Modalities in 2024
|
Lerman, Joseph B.
|
|
|
|
3 |
p. 427-437
|
artikel
|
| 35 |
Double Vision
|
Packer, Milton
|
|
2017
|
|
3 |
p. 232-235
4 p.
|
artikel
|
| 36 |
Do We Really Need More Biomarkers?
|
O’Connor, Christopher M.
|
|
2013
|
|
3 |
p. 270-271
2 p.
|
artikel
|
| 37 |
Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?
|
Vaduganathan, Muthiah
|
|
2019
|
|
3 |
p. 267-271
|
artikel
|
| 38 |
Early and Late Effects of High- Versus Low-Dose Angiotensin Receptor Blockade on Renal Function and Outcomes in Patients With Chronic Heart Failure
|
Kiernan, Michael S.
|
|
2015
|
|
3 |
p. 214-223
10 p.
|
artikel
|
| 39 |
Easy to Predict, Difficult to Prevent ∗
|
Whellan, David J.
|
|
2017
|
|
3 |
p. 226-228
3 p.
|
artikel
|
| 40 |
Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure
|
Gold, Michael R.
|
|
2017
|
|
3 |
p. 204-212
9 p.
|
artikel
|
| 41 |
Editorial Board
|
|
|
|
|
3 |
p. i-v
|
artikel
|
| 42 |
Editorial Board
|
|
|
|
|
3 |
p. A9-A13
|
artikel
|
| 43 |
Editorial Mentorship
|
O'Connor, Christopher
|
|
2014
|
|
3 |
p. 321-322
2 p.
|
artikel
|
| 44 |
Effect of Ivabradine on Early Readmissions After Hospitalization for Worsening Heart Failure
|
Borer, Jeffrey S.
|
|
2015
|
|
3 |
p. 268-269
2 p.
|
artikel
|
| 45 |
Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations
|
Rogers, Jennifer K.
|
|
2014
|
|
3 |
p. 289-297
9 p.
|
artikel
|
| 46 |
Emergency Departments, Acute Heart Failure, and Admissions
|
Pang, Peter S.
|
|
2014
|
|
3 |
p. 278-280
3 p.
|
artikel
|
| 47 |
Ethical and Moral Complexities of Left Ventricular Assist Device Deactivation
|
Rao, Anirudh
|
|
|
|
3 |
p. 599
|
artikel
|
| 48 |
Evolving Role of Galectin-3 as a Cardiac Biomarker
|
deFilippi, Christopher R.
|
|
2015
|
|
3 |
p. 253-256
4 p.
|
artikel
|
| 49 |
Exertional Dyspnea Can Now Be Graded Using Normative Reference Equations
|
Ekström, Magnus
|
|
|
|
3 |
p. 604
|
artikel
|
| 50 |
Extending the Evidence for Intravenous Iron in Patients With Heart Failure and Iron Deficiency ∗
|
Gale, Stormi E.
|
|
|
|
3 |
p. 537-538
|
artikel
|
| 51 |
Fatness, Fitness, Stiffness, and Age
|
Borlaug, Barry A.
|
|
2014
|
|
3 |
p. 247-249
3 p.
|
artikel
|
| 52 |
Full issue PDF
|
|
|
|
|
3 |
p. I-CXVI
|
artikel
|
| 53 |
Full Issue PDF
|
|
|
|
|
3 |
p. e1-e192
|
artikel
|
| 54 |
Galectin-3 in Heart Failure With Preserved Ejection Fraction
|
AbouEzzeddine, Omar F.
|
|
2015
|
|
3 |
p. 245-252
8 p.
|
artikel
|
| 55 |
General Information
|
|
|
|
|
3 |
p. A17-A18
|
artikel
|
| 56 |
Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction
|
Belkin, Maria
|
|
|
|
3 |
p. 245
|
artikel
|
| 57 |
Heart Failure Complicating Non–ST-Segment Elevation Acute Coronary Syndrome
|
Bahit, Maria Cecilia
|
|
2013
|
|
3 |
p. 223-229
7 p.
|
artikel
|
| 58 |
Heart Failure in Women
|
Lindenfeld, JoAnn
|
|
2019
|
|
3 |
p. 274-275
|
artikel
|
| 59 |
Heart Failure Management Innovation Enabled by Electronic Health Records
|
Kao, David P.
|
|
|
|
3 |
p. 223-233
|
artikel
|
| 60 |
Heart Failure Patients Need More Than Heart Failure Care ∗
|
Heidenreich, Paul
|
|
2016
|
|
3 |
p. 194-196
3 p.
|
artikel
|
| 61 |
Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor
|
Felker, G. Michael
|
|
2015
|
|
3 |
p. 193-201
9 p.
|
artikel
|
| 62 |
Heart Failure With Preserved Ejection Fraction
|
Ahmad, Tariq
|
|
|
|
3 |
p. 185-187
|
artikel
|
| 63 |
Hemodynamic Ramp Tests in Patients With Left Ventricular Assist Devices
|
Uriel, Nir
|
|
2016
|
|
3 |
p. 208-217
10 p.
|
artikel
|
| 64 |
Hop, Skip, and Jump
|
O’Connor, Christopher M.
|
|
2015
|
|
3 |
p. 273-274
2 p.
|
artikel
|
| 65 |
How Many Patients Will Benefit From a New Therapy for Chronic Systolic Heart Failure, and What Difference Does it Make? ∗
|
Borer, Jeffrey S.
|
|
2015
|
|
3 |
p. 231-233
3 p.
|
artikel
|
| 66 |
Hypertonic Saline
|
Costanzo, Maria Rosa
|
|
|
|
3 |
p. 209-211
|
artikel
|
| 67 |
ICD Versus CRT-D Implantation
|
Atwater, Brett D.
|
|
|
|
3 |
p. 158-160
|
artikel
|
| 68 |
IGFBP-7 and Outcomes in Heart Failure With Reduced Ejection Fraction
|
Adamson, Carly
|
|
|
|
3 |
p. 291-304
|
artikel
|
| 69 |
I Lost a Friend From HFpEF: William Anlyan, MD, Chancellor Emeritus and Duke University Trustee
|
O’Connor, Christopher M.
|
|
2016
|
|
3 |
p. 230-231
2 p.
|
artikel
|
| 70 |
Impact of Geographic Region on the COMMANDER-HF Trial
|
Ferreira, João Pedro
|
|
|
|
3 |
p. 201-211
|
artikel
|
| 71 |
Implementation Noise
|
O'Connor, Christopher M.
|
|
|
|
3 |
p. 211-212
|
artikel
|
| 72 |
Improvement in Cardiac Energetics by Perhexiline in Heart Failure Due to Dilated Cardiomyopathy
|
Beadle, Roger M.
|
|
2015
|
|
3 |
p. 202-211
10 p.
|
artikel
|
| 73 |
Incidence, Temporal Trends, and Prognostic Impact of Heart Failure Complicating Acute Myocardial Infarction
|
Desta, Liyew
|
|
2015
|
|
3 |
p. 234-242
9 p.
|
artikel
|
| 74 |
Increasingly Recognized Role of Right Ventricle Assessment in Cardiac Amyloidosis
|
Mishra, Tushar
|
|
2019
|
|
3 |
p. 277-278
|
artikel
|
| 75 |
Increasing the Utilization of Sac/Val in Elderly HFrEF Patients Eligible for ARNI Treatment
|
Ye, Gailin
|
|
|
|
3 |
p. 372
|
artikel
|
| 76 |
Increasing Utilization of Extended Criteria Donor Hearts for Transplantation
|
Schroder, Jacob N.
|
|
|
|
3 |
p. 438-447
|
artikel
|
| 77 |
Influence of Impaired Conduction on Exercise Hemodynamics in Patients With Preserved Ejection Fraction
|
Hogarty, Joseph P.
|
|
|
|
3 |
p. 588-590
|
artikel
|
| 78 |
In Search of Euvolemia in Heart Failure ∗
|
Katz, Stuart D.
|
|
2014
|
|
3 |
p. 306-307
2 p.
|
artikel
|
| 79 |
Inside This Issue
|
|
|
2015
|
|
3 |
p. A15-A18
nvt p.
|
artikel
|
| 80 |
Inside This Issue
|
|
|
2014
|
|
3 |
p. A12-A20
nvt p.
|
artikel
|
| 81 |
Instructions For Authors
|
|
|
2015
|
|
3 |
p. A11-A14
nvt p.
|
artikel
|
| 82 |
Instructions For Authors
|
|
|
|
|
3 |
p. A11-A16
|
artikel
|
| 83 |
Instructions For Authors
|
|
|
|
|
3 |
p. A11-A15
|
artikel
|
| 84 |
International Consortium for Health Outcomes Measurement (ICHOM): Standardized Patient-Centered Outcomes Measurement Set for Heart Failure Patients
|
Burns, Daniel J.P.
|
|
|
|
3 |
p. 212-222
|
artikel
|
| 85 |
Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?
|
Maslov, Petra Zubin
|
|
2019
|
|
3 |
p. 192-203
|
artikel
|
| 86 |
Is Dapagliflozin a Cardiac Anti-Aging Drug? ∗
|
Bayes-Genis, Antoni
|
|
|
|
3 |
p. 305-306
|
artikel
|
| 87 |
Is Heart Rate Important for Patients With Heart Failure in Atrial Fibrillation?
|
Cullington, Damien
|
|
2014
|
|
3 |
p. 213-220
8 p.
|
artikel
|
| 88 |
Is Resistance Futile?
|
Loungani, Rahul S.
|
|
|
|
3 |
p. 169-171
|
artikel
|
| 89 |
Is Salt Bad for You?
|
O’Connor, Christopher M.
|
|
2017
|
|
3 |
p. 238-239
2 p.
|
artikel
|
| 90 |
JACC: Heart Failure Series: FDA in the 21st Century
|
Fiuzat, Mona
|
|
2017
|
|
3 |
p. 229-231
3 p.
|
artikel
|
| 91 |
Left Bundle Branch Block Predicts Better Survival in Women Than Men Receiving Cardiac Resynchronization Therapy
|
Loring, Zak
|
|
2013
|
|
3 |
p. 237-244
8 p.
|
artikel
|
| 92 |
Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization
|
St. John Sutton, Martin
|
|
2017
|
|
3 |
p. 169-178
10 p.
|
artikel
|
| 93 |
Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping
|
Dimond, Matthew G.
|
|
|
|
3 |
p. 451-460
|
artikel
|
| 94 |
Left Ventricular Function Across the Spectrum of Body Mass Index in African Americans
|
Patel, Vivek G.
|
|
2017
|
|
3 |
p. 182-190
9 p.
|
artikel
|
| 95 |
Left Ventricular Shape
|
Udelson, James E.
|
|
2017
|
|
3 |
p. 179-181
3 p.
|
artikel
|
| 96 |
Living With Heart Failure With Preserved Ejection Fraction
|
Chauhan, Cynthia
|
|
2017
|
|
3 |
p. 236-237
2 p.
|
artikel
|
| 97 |
Long-Term Mortality After Cardiac Allograft Vasculopathy
|
Agarwal, Shikhar
|
|
2014
|
|
3 |
p. 281-288
8 p.
|
artikel
|
| 98 |
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab
|
Banke, Ann
|
|
2019
|
|
3 |
p. 217-224
|
artikel
|
| 99 |
Low Serum Ferritin Might Predict Incident Heart Failure
|
Cleland, John G.F.
|
|
|
|
3 |
p. 549-551
|
artikel
|
| 100 |
Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension
|
Wang, Andrew
|
|
|
|
3 |
p. 567-579
|
artikel
|
| 101 |
Meta-Analysis and Metaregression of the Treatment Effect of Intravenous Iron in Iron-Deficient Heart Failure
|
Martens, Pieter
|
|
|
|
3 |
p. 525-536
|
artikel
|
| 102 |
Micronutrients for Chronic Heart Failure
|
Witte, Klaus K.A.
|
|
2014
|
|
3 |
p. 318-320
3 p.
|
artikel
|
| 103 |
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction
|
Serenelli, Matteo
|
|
|
|
3 |
p. 188-198
|
artikel
|
| 104 |
Natriuretic Peptides and Stratification for ICD Therapy in Nonischemic Heart Failure
|
Zeitler, Emily P.
|
|
|
|
3 |
p. 172-174
|
artikel
|
| 105 |
Need to Define Severe Heart Failure
|
Bozkurt, Biykem
|
|
|
|
3 |
p. 595-598
|
artikel
|
| 106 |
Nitrate Therapy for Heart Failure
|
Gupta, Divya
|
|
2013
|
|
3 |
p. 183-191
9 p.
|
artikel
|
| 107 |
NT-proBNP and ICD in Nonischemic Systolic Heart Failure
|
Butt, Jawad H.
|
|
|
|
3 |
p. 161-171
|
artikel
|
| 108 |
Officers Page
|
|
|
|
|
3 |
p. A14
|
artikel
|
| 109 |
Optimal Positioning of Novel Heart Failure Pharmacotherapies
|
Mehmood, Muddassir
|
|
|
|
3 |
p. 242
|
artikel
|
| 110 |
Pathogenic Gut Flora in Patients With Chronic Heart Failure
|
Pasini, Evasio
|
|
2016
|
|
3 |
p. 220-227
8 p.
|
artikel
|
| 111 |
Perhexiline: Lessons for Heart Failure Therapeutics ∗
|
Cappola, Thomas P.
|
|
2015
|
|
3 |
p. 212-213
2 p.
|
artikel
|
| 112 |
Personalized Diuretic Therapy in Acute Heart Failure
|
ter Maaten, Jozine M.
|
|
|
|
3 |
p. 521-524
|
artikel
|
| 113 |
Plasma Ferritin Levels, Incident Heart Failure, and Cardiac Structure and Function
|
Aboelsaad, Iman A.F.
|
|
|
|
3 |
p. 539-548
|
artikel
|
| 114 |
Playing the Transplant Lottery
|
Rao, Shaline
|
|
|
|
3 |
p. 448-450
|
artikel
|
| 115 |
Pre-Capillary Pulmonary Hypertension and Right Ventricular Dilation Predict Clinical Outcome in Cardiac Resynchronization Therapy
|
Chatterjee, Neal A.
|
|
2014
|
|
3 |
p. 230-237
8 p.
|
artikel
|
| 116 |
Precise Exclusion Criteria Are Necessary to Define Normative Values of NT-proBNP
|
Mu, Scott Z.
|
|
|
|
3 |
p. 601-602
|
artikel
|
| 117 |
Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart Failure
|
Lala, Anuradha
|
|
|
|
3 |
p. 226-236
|
artikel
|
| 118 |
Predictors of Incident Heart Failure Diagnosis Setting
|
Tisdale, Rebecca L.
|
|
|
|
3 |
p. 347-358
|
artikel
|
| 119 |
Pregnancy in Patients With Advanced Heart Failure
|
Bhardwaj, Anju
|
|
|
|
3 |
p. 362-364
|
artikel
|
| 120 |
Prescribing Patterns to Optimize Heart Rate
|
Dierckx, Riet
|
|
2015
|
|
3 |
p. 224-230
7 p.
|
artikel
|
| 121 |
Prevalence and Prognostic Significance of Mitral Regurgitation in Acute Decompensated Heart Failure
|
Arora, Sameer
|
|
|
|
3 |
p. 179-189
|
artikel
|
| 122 |
Prevalence of Subclinical Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction
|
Yang, Eunice
|
|
|
|
3 |
p. 492-504
|
artikel
|
| 123 |
Preventing Heart Failure at the Population Level
|
Cowie, Martin R.
|
|
2019
|
|
3 |
p. 214-216
|
artikel
|
| 124 |
Primary Prevention of Heart Failure in Women
|
Daubert, Melissa A.
|
|
2019
|
|
3 |
p. 181-191
|
artikel
|
| 125 |
Prognostic Benefit of Optimum Left Ventricular Lead Position in Cardiac Resynchronization Therapy
|
Kydd, Anna C.
|
|
2014
|
|
3 |
p. 205-212
8 p.
|
artikel
|
| 126 |
Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction
|
Fuery, Michael A.
|
|
|
|
3 |
p. 479-487
|
artikel
|
| 127 |
Proposed New Conceptualization for Definition of Decompensated HF
|
Bozkurt, Biykem
|
|
|
|
3 |
p. 368-371
|
artikel
|
| 128 |
Quo Vadis Trastuzumab?
|
Barac, Ana
|
|
2019
|
|
3 |
p. 225-227
|
artikel
|
| 129 |
Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload
|
Fernandes-Silva, Miguel M.
|
|
2017
|
|
3 |
p. 157-165
9 p.
|
artikel
|
| 130 |
Racial Tension in Hypertension
|
Paulus, Walter J.
|
|
2017
|
|
3 |
p. 166-168
3 p.
|
artikel
|
| 131 |
Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure
|
Griffin, Matthew
|
|
|
|
3 |
p. 199-208
|
artikel
|
| 132 |
Renal Compression in Heart Failure
|
Boorsma, Eva M.
|
|
|
|
3 |
p. 175-183
|
artikel
|
| 133 |
Reply
|
Gheorghiade, Mihai
|
|
2015
|
|
3 |
p. 269-270
2 p.
|
artikel
|
| 134 |
Reply
|
Ezekowitz, Justin A.
|
|
2015
|
|
3 |
p. 271-272
2 p.
|
artikel
|
| 135 |
Reply
|
Vest, Amanda R.
|
|
2016
|
|
3 |
p. 236-
1 p.
|
artikel
|
| 136 |
Reply
|
Lavie, Carl J.
|
|
2016
|
|
3 |
p. 234-235
2 p.
|
artikel
|
| 137 |
Reply
|
Salah, Khibar
|
|
2016
|
|
3 |
p. 233-234
2 p.
|
artikel
|
| 138 |
Reply
|
Amsallem, Myriam
|
|
2019
|
|
3 |
p. 279-280
|
artikel
|
| 139 |
Reply
|
Jackevicius, Cynthia A.
|
|
2019
|
|
3 |
p. 276-277
|
artikel
|
| 140 |
Reply
|
Ostrominski, John W.
|
|
|
|
3 |
p. 213-214
|
artikel
|
| 141 |
Reply
|
Mancini, Donna M.
|
|
|
|
3 |
p. 215
|
artikel
|
| 142 |
Reply
|
Alvi, Raza M.
|
|
|
|
3 |
p. 249-250
|
artikel
|
| 143 |
Reply
|
Chandra, Alvin
|
|
|
|
3 |
p. 245-246
|
artikel
|
| 144 |
Reply
|
Goyal, Parag
|
|
|
|
3 |
p. 247-248
|
artikel
|
| 145 |
Reply
|
Murphy, Sean P.
|
|
|
|
3 |
p. 372-373
|
artikel
|
| 146 |
Reply
|
Zaidi, Danish
|
|
|
|
3 |
p. 600
|
artikel
|
| 147 |
Reply
|
Shetty, Naman S.
|
|
|
|
3 |
p. 603
|
artikel
|
| 148 |
Resting Heart Rate and Heart Rate Reserve in Advanced Heart Failure Have Distinct Pathophysiologic Correlates and Prognostic Impact
|
Benes, Jan
|
|
2013
|
|
3 |
p. 259-266
8 p.
|
artikel
|
| 149 |
Return on Investment in Implantable Devices
|
Steinberg, Benjamin A.
|
|
2017
|
|
3 |
p. 213-215
3 p.
|
artikel
|
| 150 |
Reviewers Hall of Fame
|
O’Connor, Christopher M.
|
|
|
|
3 |
p. 241
|
artikel
|
| 151 |
Risk Prediction Tools in Patients With Heart Failure
|
Lupón, Josep
|
|
2015
|
|
3 |
p. 267-
1 p.
|
artikel
|
| 152 |
Safety of Alpha-Adrenergic Receptor Antagonists in Heart Failure
|
Guo, Wen-Qin
|
|
2019
|
|
3 |
p. 276
|
artikel
|
| 153 |
Secretion of Prohormone of B-Type Natriuretic Peptide, proBNP1-108, Is Increased in Heart Failure
|
Costello-Boerrigter, Lisa C.
|
|
2013
|
|
3 |
p. 207-212
6 p.
|
artikel
|
| 154 |
Self-Care and All-Cause Mortality in Patients With Chronic Heart Failure
|
Kessing, Dionne
|
|
2016
|
|
3 |
p. 176-183
8 p.
|
artikel
|
| 155 |
Serial Echocardiography Using Tissue Doppler and Speckle Tracking Imaging to Monitor Right Ventricular Failure Before and After Left Ventricular Assist Device Surgery
|
Kato, Tomoko Sugiyama
|
|
2013
|
|
3 |
p. 216-222
7 p.
|
artikel
|
| 156 |
Serial NT-proBNP Measurements and Implementation of Guideline-Directed Medical Therapy ∗
|
Khan, Muhammad Shahzeb
|
|
|
|
3 |
p. 488-491
|
artikel
|
| 157 |
Serum Biomarkers in Severe Refractory Cardiogenic Shock
|
Shah, Nishant R.
|
|
2013
|
|
3 |
p. 200-206
7 p.
|
artikel
|
| 158 |
Setting the Diagnosis of Heart Failure
|
Sepehrvand, Nariman
|
|
|
|
3 |
p. 359-361
|
artikel
|
| 159 |
Setting the Stage for a Multimarker-Based Heart Failure Prevention Trial? ∗
|
Ahmad, Tariq
|
|
|
|
3 |
p. 224-225
|
artikel
|
| 160 |
Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology
|
Beale, Anna L.
|
|
2019
|
|
3 |
p. 239-249
|
artikel
|
| 161 |
Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction
|
Merrill, Miranda
|
|
2019
|
|
3 |
p. 228-238
|
artikel
|
| 162 |
Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation
|
DeFilippis, Ersilia M.
|
|
2019
|
|
3 |
p. 250-257
|
artikel
|
| 163 |
Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe
|
Magnussen, Christina
|
|
2019
|
|
3 |
p. 204-213
|
artikel
|
| 164 |
Smoking Cessation Reduces the Risk of Heart Failure
|
Yoo, Jung Eun
|
|
|
|
3 |
p. 277-287
|
artikel
|
| 165 |
Social Isolation and Loneliness in Heart Failure
|
Goodlin, Sarah J.
|
|
|
|
3 |
p. 345-346
|
artikel
|
| 166 |
Standing the Test of Time ∗
|
Lala, Anuradha
|
|
2015
|
|
3 |
p. 243-244
2 p.
|
artikel
|
| 167 |
Structural and Functional Brain Changes in Acute Takotsubo Syndrome
|
Khan, Hilal
|
|
|
|
3 |
p. 307-317
|
artikel
|
| 168 |
Subclinical Atrial Fibrillation in HFpEF
|
Ho, Jennifer E.
|
|
|
|
3 |
p. 505-507
|
artikel
|
| 169 |
Suicide in HF Patients
|
O’Connor, Christopher M.
|
|
|
|
3 |
p. 243-244
|
artikel
|
| 170 |
Surfing the Biomarker Tsunami at JACC: Heart Failure ∗
|
Januzzi Jr., James L.
|
|
2013
|
|
3 |
p. 213-215
3 p.
|
artikel
|
| 171 |
Table of Contents
|
|
|
|
|
3 |
p. A2-A7
|
artikel
|
| 172 |
Takotsubo Cardiomyopathy
|
Elkind, Mitchell S.V.
|
|
|
|
3 |
p. 318-320
|
artikel
|
| 173 |
The Association Between Atrial Fibrillation and Sudden Cardiac Death
|
Reinier, Kyndaron
|
|
2014
|
|
3 |
p. 221-227
7 p.
|
artikel
|
| 174 |
The Battle for Enrollment
|
Konstam, Marvin A.
|
|
|
|
3 |
p. 212-214
|
artikel
|
| 175 |
The Burden of Acute Heart Failure on U.S. Emergency Departments
|
Storrow, Alan B.
|
|
2014
|
|
3 |
p. 269-277
9 p.
|
artikel
|
| 176 |
The “Burden” of Secondary Mitral Regurgitation in Acute Decompensated Heart Failure ∗
|
Grayburn, Paul A.
|
|
|
|
3 |
p. 190-191
|
artikel
|
| 177 |
The 30-Day Readmission Metric for Heart Failure
|
Adedinsewo, Demi
|
|
2017
|
|
3 |
p. 240-
1 p.
|
artikel
|
| 178 |
The Effect of Multiple Micronutrient Supplementation on Left Ventricular Ejection Fraction in Patients With Chronic Stable Heart Failure
|
McKeag, Nicholas A.
|
|
2014
|
|
3 |
p. 308-317
10 p.
|
artikel
|
| 179 |
The End of Endomyocardial Biopsy?
|
Holzhauser, Luise
|
|
|
|
3 |
p. 263-276
|
artikel
|
| 180 |
The Hope That Early Detection Can Tip the Scale Towards Heart Failure Prevention ∗
|
Lewis, Eldrin F.
|
|
2017
|
|
3 |
p. 191-193
3 p.
|
artikel
|
| 181 |
The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials
|
Oghina, Silvia
|
|
|
|
3 |
p. 169-178
|
artikel
|
| 182 |
The Jury Is Still Out on A-Type Natriuretic Peptide Deficiency Relative to B-Type Natriuretic Peptides ∗
|
Gandhi, Parul U.
|
|
|
|
3 |
p. 475-478
|
artikel
|
| 183 |
The “Obesity Paradox” Is Not a Paradox: Time to Focus on Effective Treatments
|
Shrier, Ian
|
|
2016
|
|
3 |
p. 234-
1 p.
|
artikel
|
| 184 |
Time Is “Not” on Your Side When Managing Cardiogenic Shock, a Loaded Ventricle, and VA-ECMO ∗
|
Kapur, Navin K.
|
|
|
|
3 |
p. 331-333
|
artikel
|
| 185 |
Timing of Active Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy
|
Schrage, Benedikt
|
|
|
|
3 |
p. 321-330
|
artikel
|
| 186 |
Toward Improved Understanding of Potential Harm in Heart Failure
|
Alvarez, Paulino
|
|
|
|
3 |
p. 246-247
|
artikel
|
| 187 |
Treatment With an Interatrial Shunt in Heart Failure
|
Paitazoglou, Christina
|
|
|
|
3 |
p. 591-594
|
artikel
|
| 188 |
Trends in Short- and Long-Term Outcomes for Takotsubo Cardiomyopathy Among Medicare Fee-for-Service Beneficiaries, 2007 to 2012
|
Murugiah, Karthik
|
|
2016
|
|
3 |
p. 197-205
9 p.
|
artikel
|
| 189 |
Tricuspid Regurgitation
|
Vader, Justin M.
|
|
|
|
3 |
p. 564-566
|
artikel
|
| 190 |
Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction
|
Adamo, Marianna
|
|
|
|
3 |
p. 552-563
|
artikel
|
| 191 |
Understanding the Heterogeneity in Volume Overload and Fluid Distribution in Decompensated Heart Failure Is Key to Optimal Volume Management
|
Miller, Wayne L.
|
|
2014
|
|
3 |
p. 298-305
8 p.
|
artikel
|
| 192 |
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure
|
Bachmann, Katherine N.
|
|
|
|
3 |
p. 192-200
|
artikel
|
| 193 |
Utility of Patient-Reported Outcome Instruments in Heart Failure
|
Kelkar, Anita A.
|
|
2016
|
|
3 |
p. 165-175
11 p.
|
artikel
|
| 194 |
Validated, Electronic Health Record Deployable Prediction Models for Assessing Patient Risk of 30-Day Rehospitalization and Mortality in Older Heart Failure Patients
|
Eapen, Zubin J.
|
|
2013
|
|
3 |
p. 245-251
7 p.
|
artikel
|
| 195 |
Variable Contribution of Heart Failure to Quality of Life in Ambulatory Heart Failure With Reduced, Better, or Preserved Ejection Fraction
|
Joyce, Emer
|
|
2016
|
|
3 |
p. 184-193
10 p.
|
artikel
|
| 196 |
We Are Not Alone
|
Tang, W.H. Wilson
|
|
2016
|
|
3 |
p. 228-229
2 p.
|
artikel
|
| 197 |
What Medicare Knows About the Takotsubo Cardiomyopathy ∗
|
Sharkey, Scott W.
|
|
2016
|
|
3 |
p. 206-207
2 p.
|
artikel
|
| 198 |
Where There’s Smoke, There’s Fire
|
Reza, Nosheen
|
|
|
|
3 |
p. 288-290
|
artikel
|
| 199 |
Worsening Renal Function in Acute Decompensated Heart Failure
|
Núñez, Julio
|
|
2016
|
|
3 |
p. 232-233
2 p.
|
artikel
|
Tijdschrift beschrijving